Peptide Atlas · Peptide

Dulaglutide

Dulaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist given as a once-weekly subcutaneous injection.

established

provisional
2 citations
0 discussions
0 followers
LY2189265
Trulicity

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

established — replicated in humans, or settled by a regulator

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

Evidence, kept apart

The Atlas never mixes evidence types into one blob. Each claim below carries the tier it actually sits in; an unresolved citation is shown and does not move the page.

Evidence map for Dulaglutide. Tier reflects study design, not enthusiasm.
Claim	Tier	Source
AWARD-6: dulaglutide versus liraglutide, phase 3	established	pmid 25018121
REWIND cardiovascular outcomes trial	established	pmid 31189511

Unanswered questions

No open questions on file. Either everything about this molecule is known, or nobody has admitted what is not.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.